ICMR recommends interventions to meet gap in machines needed for cancer care
equitable cancer care
.
Published in the BMC Cancer journal, the study stated that 28.5 per cent of cancer patients receive radiotherapy, which is lower than the estimated optimal rate of 58.4 per cent.
Breast, head and neck, lung and cervical cancer account for 60 per cent of India's radiotherapy needs, it said.
Data from the Australian Collaboration for Cancer Outcomes Research and Evaluation (CCORE) were used by the researchers of ICMR-National Centre for Disease Informatics and Research, Bengaluru, for conducting the study.
Epidemiological data on stage, subsite and histology from the National Cancer Registry Programme were used to assess the optimal utilisation proportion for India. A sensitivity analysis was carried out.
Similarly, the optimal radiotherapy fraction has also been calculated. These measures have been used to estimate the existing radiotherapy utilisation gap by comparing with the current radiotherapy utilisation from the cancer registry as well as to estimate the optimal radiotherapy machines required for the country.
"This study provides a comprehensive assessment of radiotherapy demand and existing gaps in radiotherapy utilisation and in the number of machines in India based on an epidemiological analysis of the cancer burden from the National Cancer Registry Programme. Our analysis shows that approximately 58 per cent of all cancer cases in India should ideally receive radiotherapy based on clinical indications.
"However, the current radiotherapy utilisation in India is only 28.5 per cent, which is less than half of the required level," the researchers said.
The study also recommended that India would require 1,585 to 2,545 machines, which may increase to a range of 2,016 to 2,291 external beam radiotherapy machines if the assumptions from previous benchmark studies are followed.
The burden of four cancer sites -- breast, head and neck, lung and cervical cancer -- constitutes around 60 per cent of the total radiotherapy requirement for cancer care in India, the study said.
This points towards an increasing demand for radiotherapy in the coming years as there is expected to be a 70-100 per cent increase in breast, head and neck and lung cancer in low and middle income countries (LMIC). Radiotherapy utilisation of most cancer sites is lower compared to optimal radiotherapy utilisation.
Among the major indicated cancer sites, the deficit is more prominent in lymphoma and lung cancer (relative deficit of more than 70 per cent), followed by prostate, breast and oesophagus, it said.
The study mentioned that India accounts for 7 per cent of global cancer incidence, ranking third after China and the USA. By the end of 2025, the incidence of cancer in India is projected to reach 1.57 million cases, posing a significant public health challenge.
As the fifth leading cause of death in the country, cancer demands urgent attention to improve prevention, diagnosis and treatment, it said.
Radiotherapy, a cornerstone of cancer treatment, plays a crucial role in controlling tumour growth, reducing tumour size pre-surgery, and alleviating pain in advanced stages.
However, its availability in low and middle-income countries like India remains insufficient due to high setup and operational costs, creating a significant gap between demand and resources.
The World Health Organization (WHO) recommends a minimum of one radiotherapy machine (external radiotherapy machine) per million population, with an optimal target of four per million, the study stated.
For India's projected population of 1.45 billion in 2025, this translates to a need for a minimum of 1,450 machines. Yet, only 794 megavoltage (MV) machines are currently available. The shortfall is about 45 per cent from the minimal required standard, the study said.
The study highlighted that in India, greater investment is needed to expand radiotherapy facilities to meet the growing demands of cancer patients.
"Aside from increasing the number of equipment, addressing the inequitable distribution of radiotherapy services is also crucial. To align with the country's cancer burden and ongoing cancer control efforts, India must meet evidence-based targets for radiotherapy machine availability.
"As a part of this, India is also ramping up efforts to develop and deploy affordable indigenous radiotherapy machines to improve access and reduce dependence on costly imports," the study stated.
Furthermore, a detailed situational study of radiation equipment deployment with its features and complexity, utilisation and throughput is required for informed planning and policymaking. Cancer screening and early detection programmes can facilitate the diagnosis of cancers at earlier stages. This could reduce the required quantum of radiotherapy shortly and thus, improve the overall survival of patients, the study said.
The cancer registry data informs the policy-makers to identify gaps in radiotherapy access, assess resource needs and guide decisions to ensure equitable and effective cancer care delivery.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Print
2 hours ago
- The Print
‘Must take proactive steps'—PM Modi reiterates concern over obesity crisis in I-Day address
Modi reinforced his previous recommendations to address this, urging families to purchase 10 percent less cooking oil, and reduce its consumption by the same margin on a regular basis. 'When discussing fitness, I am compelled to raise an important concern. Obesity is becoming a significant challenge that every family should take seriously. We must take proactive steps to protect ourselves from it,' the prime minister said. New Delhi: Prime Minister Narendra Modi has once again raised concerns about the issue of obesity, stressing on the need for collective action to tackle the crisis. In his address at Red Fort in Delhi on the occasion of the 79th Independence Day, Modi highlighted expert forecasts indicating that one in every three individuals in the country could become obese in near future. A 2023 survey by the Indian Council of Medical Research (ICMR) and Madras Diabetes Research Foundation (MDRF) had shown that 25.4 crore Indians or 28.6 percent of the population had generalised obesity. This survey had estimated the number of people with abdominal obesity at 351 million, or 39.5 percent of the population. The ICMR-National Institute of Nutrition, in its dietary guidelines last year, had noted that there is rising prevalence of overweight and obesity in several states, adding that 56.4 percent of India's total disease burden is due to unhealthy diets with a major focus on carbohydrates. Obesity, now recognised as a chronic, relapsing disease, is a major risk factor for diabetes, and is found to be linked to over 200 health complications, including hypertension, dyslipidemia or high blood cholesterol, coronary heart disease, some types of cancers and obstructive sleep apnea, among others. The World Health Organization (WHO) defines overweight and obesity in adults using body mass index. Those with a BMI between 25 and 30 kilograms per square metre are considered overweight, while people with a BMI of more than 30 kilograms per square metre are classified as obese. However, according to experts, India has a larger problem of abdominal obesity, characterised by fat deposition around crucial internal organs, but comparatively thinner limbs, which throws its own set of challenges. The growing obesity crisis has prompted Modi, on several occasions this year, to make a pitch for efforts to curb the epidemic. In his monthly radio broadcast in February, he had first called on people to reduce the use of cooking oils commonly found in unhealthy food. He had also previously urged people to adopt an active and healthy lifestyle in order to prevent obesity. This year, India saw the launch of two drugs—Wegovy by Novo Nordisk and Mounjaro by Eli Lilly and Company—that have been global smash hits for years for obesity treatment exclusively. (Edited by Mannat Chugh) Also Read: 82.5 mn Indians were 'obese' in 2022, shows Lancet study. Doctors, nutritionists say 'tip of iceberg'
NDTV
4 hours ago
- NDTV
78 Years Of Indian Healthcare: Milestones To Celebrate On Independence Day
Since 1947, India's healthcare journey has spanned eradication of ancient scourges, the building of premier institutions, and the digital knit-work of services reaching our most remote villages. The post-Independence decades saw the All India Institute of Medical Sciences (AIIMS) established by an Act of Parliament in 1956, creating a national standard for medical education and research. Soon after, the Indian Council of Medical Research (ICMR), rechristened from the pre-Independence IRFA in 1949, drove indigenous science to guide policy and practice. These foundations enabled massive public-health offensives: the Expanded Programme on Immunization (1978) and the Universal Immunization Programme (1985) laid the groundwork for India's smallpox-free status (1977) and, later, WHO's polio-free certification (2014) for the South-East Asia Region with India as a linchpin. In the 2000s, focused missions like the National Health Mission and game-changers such as Janani Suraksha Yojana accelerated safe motherhood and institutional deliveries. The last decade added financial protection (Ayushman Bharat PM-JAY), nationwide telemedicine (eSanjeevani), and a secure, consent-driven digital health backbone (Ayushman Bharat Digital Mission). This Independence Day, here are the milestones that explain how far we've come and what still lies ahead. The Milestones That Changed Indian Health 1. 1949-1956: Strong scientific and clinical pillars-ICMR and AIIMS Post-Independence, IRFA was renamed the Indian Council of Medical Research (ICMR) in 1949, and played a central role in shaping India's research agenda. In 1956, Parliament enacted the AIIMS Act to create AIIMS New Delhi, a model of tertiary care and medical education that later inspired new AIIMS across India. These institutions seeded evidence-based policy and world-class training, crucial in everything from vaccine trials to disease surveillance. 2. 1977-1980: Smallpox disappears from India-global eradication follows India reported its last smallpox case in 1975; by 1977 the country was smallpox-free, feeding into WHO's 1980 declaration of global eradication-the first human disease ever eliminated. This public-health triumph showcased the power of disease surveillance and vaccination at scale. It proved India could execute complex, last-mile campaigns, knowledge later applied to polio and routine immunization. 3. 1978-1985: From EPI to UIP-the world's largest routine immunization system The Expanded Programme on Immunization (1978) evolved into the Universal Immunization Programme (UIP) in 1985, now among the largest in the world, delivering vaccines free of cost under the National Immunization Schedule. UIP conducts millions of sessions annually and protects against 11 vaccine-preventable diseases nationally-building population immunity and cutting child mortality. Today, the UIP targets approximately 2.67 crore newborns and 2.9 crore pregnant women, annually, and has played a key role in eliminating maternal and neonatal tetanus in 2015. 4. 1995-2014: Pulse Polio to Polio-free certification Launched nationally in 1995, Pulse Polio mobilized health workers to immunize close to 170 million children during each National Immunization Day. In 2014, WHO certified the South-East Asia Region, including India, as polio-free. The programme refined micro-planning, cold-chain management and social mobilization, skills reused during COVID-19 vaccination and other campaigns. 5. 2005 onwards: Safe motherhood and institutional deliveries-Janani Suraksha Yojana Under the National Health Mission, the Janani Suraksha Yojana (JSY) incentivized facility-based childbirth, particularly among low-income women. Over time, India's institutional-delivery rates rose sharply, contributing to declines in maternal and neonatal deaths. India's Maternal Mortality Ratio fell to 97 per 100,000 live births in 2018-20 (SRS Special Bulletin), marking dramatic progress in two decades. 6. Child survival gains: Infant Mortality Rate keeps falling According to the Sample Registration System (SRS), India's Infant Mortality Rate (IMR) declined to 26 per 1,000 live births in 2022, continuing a multi-year downward trend. Immunization, skilled birth attendance, and better newborn care have been key drivers. Fewer infant deaths reflect stronger primary care, timely vaccines, and better referral systems. 7. 1990s-2020s: Turning the tide on HIV with NACO The National AIDS Control Organisation (NACO) built a surveillance- and evidence-driven response. India's HIV epidemic has remained low-prevalence, with continued declines in new infections and AIDS-related mortality; the 2023 technical estimates and fact sheets summarize the progress and gaps. Successive National AIDS Control Programmes mainstreamed prevention, testing, and free ART, supported by law and guidelines. 8. 2018: Financial protection at scale-Ayushman Bharat PM-JAY Ayushman Bharat PM-JAY provides cashless hospitalisation cover of INR 5 lakh per entitled family each year, targeting around 55 crore beneficiaries (bottom 40% of the population). By design, it reduces catastrophic health expenditure and widens access to secondary/tertiary care via empanelled public and private hospitals. PM-JAY complements primary-care strengthening at Health & Wellness Centres under the broader Ayushman Bharat umbrella. 9. 2020-present: Telemedicine goes mainstream-eSanjeevani The MoHFW's free National Telemedicine Service, eSanjeevani, now enables crores of doctor-to-patient and doctor-to-doctor consultations, improving access in rural and remote geographies and decongesting hospitals. Peer-reviewed analyses document its rapidly expanding footprint and potential to ease systemic inequities. Digital OPDs cut travel/time costs, promote early care-seeking, and have become part of routine delivery in many states. 10. 2021-present: The Ayushman Bharat Digital Mission (ABDM)-India's health data rails The ABDM is building a nationwide, consent-based digital health stack: ABHA (digital health IDs), Health Facility Registry, registries for providers, and interoperable health records. The aim is seamless, privacy-respecting portability of your health history across systems, improving safety and continuity of care. As adoption grows, ABDM can reduce duplicate tests, enable secure referrals, and power data-driven quality improvement. India also issued EHR standards to guide interoperability. 11. Building a culture of donation via NOTTO and transplants India created a dedicated National Organ & Tissue Transplant Organization (NOTTO) under the DGHS to coordinate organ donation, maintain registries, and standardize practice. The latest initiatives include awareness drives and digital pledge platforms integrated with ABDM. Streamlined systems and citizen pledges can narrow the gap between need and availability of life-saving organs. What India's Progress Matters, And How You Can Help Every citizen of India has the right to access healthcare, and it is equally the duty of every citizen to support the nation's healthcare mission through the following steps. Keep immunization on track: Check your family's vaccine status with your nearest health facility; UIP vaccines are free. Use digital health responsibly: Create your ABHA and link records only with consent; ABDM is built around privacy and portability. Leverage PM-JAY (if eligible): Verify eligibility and hospital networks before planned admissions. Adopt tele-OPD when appropriate: eSanjeevani can save time for routine follow-ups and primary care. Consider an organ-donor pledge: A few minutes today can save lives tomorrow. From eradicating smallpox and polio to digitizing health services, India's 78-year arc is a story of scale, science, and steady improvements in survival and financial protection. The next leap, stronger primary care, equitable access, and data-driven quality, will come faster if all of us stay informed, vaccinated, and engaged. Disclaimer: This content including advice provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information. Sources: WHO; MoHFW (NHM/UIP, Pulse Polio, EHR, eSanjeevani); AIIMS Act; ICMR; Registrar General of India (SRS); NACO (HIV estimates/factsheets); NHA (PM-JAY); ABDM; NOTTO.
Time of India
13 hours ago
- Time of India
From Independence to Innovation: How India and Genomics Grew Together
The 1940s saw the beginning of two remarkable stories. First is India's independence in 1947, and second, the pioneering science of genomics in 1944. Over the past eight decades, India's development and the evolution of genomics have reflected each other's spirit, deeply rooted in developing indigenous capabilities, driven by innovation, and inspired by the vision of a better India. Although DNA was discovered in the latter half of the 19th century, when Friedrich Miescher isolated the hereditary material that was later understood to be DNA, the attempt to decode it was made only in 1944 – when Oswald Avery, Colin MacLeod, and Maclyn McCarty demonstrated its role as carrier of genetic information, laying the foundation for the genomic era. The 1950s & 60s witnessed India's investment in building expertise, with the establishment of CSIR, ICMR, and the IITs. Similarly, on the other side, expertise in genomics was evolving, with Rosalind Franklin's X-ray images showing the DNA structure, Watson and Crick deciphering this structure, and early tools for reading it beginning to emerge. During the 1960s and 70s as India launched its space program, expanded higher education, and began investing in biotechnology, on the genomics front, Frederick Sanger, Allan Maxam, and Walter Gilbert developed methods to sequence DNA and genomics witnessed the birth of recombinant DNA technology giving way to the development of the first drug, human insulin, in 1982. The 1990s brought global integration for India. India's market was unlocked because of Economic liberalisation, unleashing new opportunities in IT, healthcare, and biotechnology. It was also a turning point in the genomics revolution with the launch of the Human Genome Project , aided by automated DNA sequencing and the mapping of disease-related genes. The project was aimed at identifying all the genes in human DNA and determining the sequences of the 3 billion base pairs that make up that DNA. The project took 13 years to complete. Its results opened doors to a new era of precision medicine and targeted disease management. In parallel, the dawn of the millennium also ushered in India as a global services hub. For Indian healthcare, this was also the era of several breakthroughs in clinical research and generics. The last couple of decades have been defined by leadership and innovation. India's digital revolution and the start-up boom showed the world its ability to lead in both scale and speed. In genomics, new technologies such as CRISPR genome editing and next-generation sequencing (NGS) have brought rapid improvements in throughput and cost, making NGS mainstream for research and clinical applications. Global quality genetic diagnostic tests, which can identify the root cause of complex diseases, are now available in India at affordable costs. High-end genetic tests developed in India and validated and backed by credible research stand testimony to India's scientific excellence, innovation, and talent, while also reiterating the country's commitment to its Make in India initiative. Population-scale projects like the Genome India Project aimed at sequencing one million genomes, a national effort by the Department of Biotechnology (DBT) to build a comprehensive reference genome for India, reflect India's contribution to advancing genomics, strengthening precision medicine and ensuring that genomics led early intervention and disease management are accessible to India's diverse and dynamic landscape. As we celebrate the 79th year of independent India, this reflection on India's remarkable journey in parallel with the journey of the source code of our life, our DNA, highlights not just the freedom of governance, but the freedom to have healthier, longer, and better lives. The article is written by Dr Venkataswamy Eswarachari, Senior Director, Lab Operations, MedGenome (DISCLAIMER: The views expressed are solely of the author and does not necessarily subscribe to it. shall not be responsible for any damage caused to any person/organisation directly or indirectly)
